Which healthcare specialties are involved in managing patients with CSU, and how can multidisciplinary care be optimized?
What are the comorbidities that are most seen in patients with CSU, and how do these affect your management plan?

Related Content

CAR NK cells | Image credit: MD Anderson

May 12th 2025

For Patients Who Cannot Wait, This Off-the-Shelf CAR NK Treatment for AML Leaves Healthy Cells Alone

Stephen Strickland, MD, MSCI Interview by Mary Caffrey

First part of a 2-part interview with Stephen Strickland, MD, MSCI, director of leukemia research for Sarah Cannon Research Institute. Strickland recently presented data from a phase 1 trial of SENTI-202, an investigational chimeric antigen receptor (CAR) natural killer (NK) cell therapy.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

Nurse talking to Black patient in waiting room | Image credit: DC Studio - stock.adobe.com

May 10th 2025

IPF Trial Practices Often Exclude Certain Patients, Perspectives

Jared Kaltwasser

Clinical trials for idiopathic pulmonary fibrosis could benefit from improved patient engagement to include diverse perspectives and inclusive practices.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

May 9th 2025

Health Outcomes Under Full-Risk Medicare Advantage vs Traditional Medicare

Kenneth Cohen, MD Boris Vabson, PhD Jennifer Podulka, MPAff Omid Ameli, MD, DrPH Kierstin Catlett, PhD Nathan Smith, PhD Megan S. Jarvis, MS Jane Sullivan, MPH Caroline Goldzweig, MD, MSHS Susan Dentzer, MS

Physician groups under 2-sided risk–based Medicare Advantage provide care associated with higher quality and efficiency compared with care by these same groups under fee-for-service Medicare.

Physician holding MMR vaccine | Image Credit: Leigh Prather - stock.adobe.com

May 9th 2025

Measles Cases Surge Amid Declining Vaccination Rates

Brooke McCormick

Measles cases surge in the US as vaccination rates decline, raising concerns about outbreaks and public health under Robert F. Kennedy Jr's leadership.

Related Content

May 12th 2025

For Patients Who Cannot Wait, This Off-the-Shelf CAR NK Treatment for AML Leaves Healthy Cells Alone

Stephen Strickland, MD, MSCI Interview by Mary Caffrey

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

May 10th 2025

IPF Trial Practices Often Exclude Certain Patients, Perspectives

Jared Kaltwasser

Clinical trials for idiopathic pulmonary fibrosis could benefit from improved patient engagement to include diverse perspectives and inclusive practices.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

May 9th 2025

Health Outcomes Under Full-Risk Medicare Advantage vs Traditional Medicare

Physician groups under 2-sided risk–based Medicare Advantage provide care associated with higher quality and efficiency compared with care by these same groups under fee-for-service Medicare.

May 9th 2025

Measles Cases Surge Amid Declining Vaccination Rates

Brooke McCormick

Measles cases surge in the US as vaccination rates decline, raising concerns about outbreaks and public health under Robert F. Kennedy Jr's leadership.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions